MOLOGEN Competitors and Similar CompaniesClear all
MOLOGEN's competitors and similar companies include Immunocore.
 MOLOGEN MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. |  Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. | |
Founding Date | Founding Date 1998 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Berlin, DE HQ | Locations Milton, GB HQ Conshohocken, US Rockville, US |
Employees | Employees 4710% decrease | Employees 493 |
Financial | ||
Revenue (est.) | Revenue (est.) €81k (FY, 2019) | Revenue (est.) $400m (FY, 2025) |
Cost of goods | Cost of goods €2m (FY, 2019) | Cost of goods $5.1m (FY, 2025) |
Gross profit | Gross profit (€1.5m) (FY, 2019) | Gross profit $414.7m (FY, 2025) |
Net income | Net income (€10.3m) (FY, 2019) | Net income ($35.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Immunocore
HQ
Milton, GB
Employees
493
Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases.
View company